𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Insulin and glucagon secretion in diabetic and non-diabetic patients with circulating islet cell antibodies

✍ Scribed by A. Tiengo; G. F. Del Prete; R. Nosadini; C. Betterle; C. Garotti; G. Bersani


Publisher
Springer
Year
1977
Tongue
English
Weight
603 KB
Volume
13
Category
Article
ISSN
0012-186X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Insulin autoantibodies are associated wi
✍ J. Ludvigsson; C. Binder; T. Mandrup-Poulsen πŸ“‚ Article πŸ“… 1988 πŸ› Springer 🌐 English βš– 572 KB

Blood was drawn from 74 children, 3-16 years old, at diagnosis of Type 1 (insulin-dependent) diabetes and before the first insulin injection. Insulin autoantibodies were detected with a polyethylen-glycol-method in 27/74 (36.4%) and with an immuno-electrophoretic method in 6/74 (8.1%). Islet cell cy

Insulin autoantibodies in the pre-diabet
✍ B. M. Dean; F. Becker; J. M. McNally; A. C. Tarn; G. Schwartz; E. A. M. Gale; G. πŸ“‚ Article πŸ“… 1986 πŸ› Springer 🌐 English βš– 448 KB

IgG and IgM class insulin autoantibodies were measured by an enzyme-linked immunosorbent assay in sera from members of the Barts-Windsor-Middlesex prospective family study for Type I (insulin-dependent) diabetes. One hundred and twelve individuals from 28 families were selected for study on the basi

Insulin secretion is decreased in non-di
✍ Martha RodrΓ­guez-MorΓ‘n; Fernando Guerrero-Romero πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 114 KB

## Abstract ## Background Magnesium modulates insulin‐mediated glucose uptake but data regarding its role in insulin secretion are scarce; therefore, in this study we determined whether decreased serum magnesium levels are associated with the impairment of insulin secretion in non‐diabetic individ

Left Ventricular Hypertrophy in Non-insu
✍ Nielsen, F.S; Ali, S.; Rossing, P.; Bang, L.E.; Svendsen, T.L.; Gall, M.-A.; Smi πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 153 KB πŸ‘ 2 views

The aim of our cross-sectional case-control study was to evaluate putative mechanisms of the increased cardiac morbidity and mortality in NIDDM patients with or without diabetic nephropathy. Fifty-one NIDDM patients with diabetic nephropathy (38 males, age 61 Β± 8 years, group 1), 53 NIDDM patients w